Han HS - Search Results

1

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.

Khatri VM, Mills MN, Oliver DE, Yu HM, Vogelbaum MA, Forsyth PA, Soliman HH, Han HS, Ahmed KA. Khatri VM, et al. Among authors: han hs. J Neurooncol. 2023 Aug;164(1):191-197. doi: 10.1007/s11060-023-04402-7. Epub 2023 Jul 25. J Neurooncol. 2023. PMID: 37490232

2

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.

Soliman HH, Jackson E, Neuger T, Dees EC, Harvey RD, Han H, Ismail-Khan R, Minton S, Vahanian NN, Link C, Sullivan DM, Antonia S. Soliman HH, et al. Oncotarget. 2014 Sep 30;5(18):8136-46. doi: 10.18632/oncotarget.2357. Oncotarget. 2014. PMID: 25327557 Free PMC article. Clinical Trial.

3

A phase I study of indoximod in patients with advanced malignancies.

Soliman HH, Minton SE, Han HS, Ismail-Khan R, Neuger A, Khambati F, Noyes D, Lush R, Chiappori AA, Roberts JD, Link C, Vahanian NN, Mautino M, Streicher H, Sullivan DM, Antonia SJ. Soliman HH, et al. Among authors: han hs. Oncotarget. 2016 Apr 19;7(16):22928-38. doi: 10.18632/oncotarget.8216. Oncotarget. 2016. PMID: 27008709 Free PMC article. Clinical Trial.

4

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer.

Soliman H, Khambati F, Han HS, Ismail-Khan R, Bui MM, Sullivan DM, Antonia S. Soliman H, et al. Among authors: han hs. Oncotarget. 2018 Jan 10;9(11):10110-10117. doi: 10.18632/oncotarget.24118. eCollection 2018 Feb 9. Oncotarget. 2018. PMID: 29515795 Free PMC article.

5

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2⁺ breast cancer.

Costa R, Zaman S, Sharpe S, Helenowski I, Shaw C, Han H, Soliman H, Czerniecki B. Costa R, et al. Drug Des Devel Ther. 2019 Jan 14;13:309-316. doi: 10.2147/DDDT.S188925. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 30679903 Free PMC article. Review.

6

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.

Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Figura NB, et al. Among authors: han hs. Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11. Breast Cancer Res Treat. 2019. PMID: 30859348

7

A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast Cancer.

Shafique M, Ismail-Khan R, Extermann M, Sullivan D, Goodridge D, Boulware D, Hogue D, Soliman H, Khong H, Han HS. Shafique M, et al. Among authors: han hs. Oncologist. 2019 Jul;24(7):887-e416. doi: 10.1634/theoncologist.2019-0231. Epub 2019 Apr 17. Oncologist. 2019. PMID: 30996012 Free PMC article. Clinical Trial.

8

Breast leptomeningeal disease: a review of current practices and updates on management.

Figura NB, Rizk VT, Armaghani AJ, Arrington JA, Etame AB, Han HS, Czerniecki BJ, Forsyth PA, Ahmed KA. Figura NB, et al. Among authors: han hs. Breast Cancer Res Treat. 2019 Sep;177(2):277-294. doi: 10.1007/s10549-019-05317-6. Epub 2019 Jun 17. Breast Cancer Res Treat. 2019. PMID: 31209686 Review.

9

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

Figura NB, Potluri TK, Mohammadi H, Oliver DE, Arrington JA, Robinson TJ, Etame AB, Tran ND, Liu JK, Soliman H, Forsyth PA, Sahebjam S, Yu HM, Han HS, Ahmed KA. Figura NB, et al. Among authors: han hs. J Neurooncol. 2019 Sep;144(3):583-589. doi: 10.1007/s11060-019-03260-6. Epub 2019 Aug 9. J Neurooncol. 2019. PMID: 31399935

10

Management of brain metastases in breast cancer: a review of current practices and emerging treatments.

Mills MN, Figura NB, Arrington JA, Yu HM, Etame AB, Vogelbaum MA, Soliman H, Czerniecki BJ, Forsyth PA, Han HS, Ahmed KA. Mills MN, et al. Among authors: han hs. Breast Cancer Res Treat. 2020 Apr;180(2):279-300. doi: 10.1007/s10549-020-05552-2. Epub 2020 Feb 6. Breast Cancer Res Treat. 2020. PMID: 32030570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,403 results

Search Page